Page 19 - Report Final MMIX 31 Des 2022
P. 19
These financial statements are originally issued in Indonesian language.
- 8 -
PT MULTI MEDIKA INTERNASIONAL Tbk PT MULTI MEDIKA INTERNASIONAL Tbk
CATATAN ATAS LAPORAN KEUANGAN (Lanjutan) NOTES TO THE FINANCIAL STATEMENTS (Continued)
UNTUK 31 DESEMBER 2022 DAN 2021 DECEMBER 31, 2022 AND 2021
(Disajikan dalam Rupiah, kecuali dinyatakan lain) (Expressed in Rupiah, unless otherwise stated)
b. Penawaran Umum Saham Entitas b. Public Offering of the Entity’s Shares
Pada tanggal 8 September 2022, melalui On September 8, 2022, through the Cover Letter of
Surat Pengantar Pernyataan Pendaftaran Registration Statement No. 024/MMI/IX/2022,
No. 024/MMI/IX/2022, Entitas telah menawarkan the Entity has offered its shares to the public
sahamnya kepada masyarakat melalui pasar modal through the capital market amounting to
sejumlah 600.000.000 lembar saham dengan nilai 600,000,000 shares with a nominal value of Rp 25
nominal Rp 25 per saham dengan harga penawaran per share with an offering price of Rp 190 per
Rp 190 per saham. Pada tanggal 28 November 2022, share. On November 28, 2022, based on the Decree
berdasarkan Keputusan Dewan Komisioner Otoritas of the Board of Commissioners of the Financial
Jasa Keuangan (OJK) No. KEP-84/D.04/2022 Services Authority (OJK) No. KEP-84/D.04/2022
tentang Penetapan Saham PT Multi Medika concerning the Determination of PT Multi Medika
Internasional Tbk sebagai Efek Syariah, Internasional Tbk's Shares as Sharia Securities,
Entitas telah memperoleh Surat Pemberitahuan the Entity has obtained an Effective Notice of
Efektif Pernyataan Penawaran dengan Offering Statement with No. S-244/D.04/2022.
No. S-244/D.04/2022. Selisih lebih jumlah yang The excess amount received from the issuance of
diterima dari pengeluaran saham terhadap nilai stock over its face value amounting to
nominalnya sebesar Rp 99.000.000.000 dicatat Rp 99,000,000,000 is recorded in the “Additional
dalam akun “Tambahan Modal Disetor” setelah Paid-in Capital” account, after deducting the total
dikurangi total biaya emisi saham sebesar shares issuance cost of Rp 5,085,676,808
Rp 5.085.676.808 (lihat Catatan 22). (see Note 22).
Pada tanggal 5 Desember 2022, seluruh saham On December 5, 2022 all the Entity’s shares have
Entitas telah tercatat pada Bursa Efek Indonesia. been listed at the Indonesia Stock Exchange.
c. Dewan Komisaris, Direksi, Komite Audit dan c. The Board of Commissioners, Directors, Audit
Karyawan Committee and Employees
Manajemen kunci Entitas meliputi seluruh anggota The Entity’s key management includes all members
Komisaris dan Direksi. of the Commissioners and Directors.
Susunan Dewan Komisaris dan Direksi Entitas pada The composition of the Entity’s Board of
tanggal 31 Desember 2022 adalah sebagai berikut: Commissioners and Director as of
December 31, 2022 are as follows:
Dewan Komisaris Board of Commissioners
Komisaris Independen : Togu Cornetius Simanjuntak : Independent Commissioner
Komisaris : Hillary Josephine : Commissioners
Allen Feliciano
Direksi Director
Direktur Utama : Mengky Mangarek : President Director
Direktur Eveline Natalia Susanto Director
Susunan Dewan Komisaris dan Direksi Entitas pada The members of the Board of
tanggal 31 Desember 2021 adalah sebagai berikut: Commissioners and Directors of the Entity as of
December 31, 2021 is as follows:
Dewan Komisaris Board of Commissioners
Komisaris Utama : Eveline Natalia Susanto : President Commissioner
Komisaris : Hillary Josephine : Commissioners
Allen Feliciano
Direksi Directors
Direktur : Mengky Mangarek : Director